Cargando…

Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism

SUMMARY: Although bone disease and stone disease are the universally accepted classical manifestations of primary hyperparathyroidism, clinical parathyroid bone disease is rarely seen today in the United States (<5% of patients) and Western Europe. Nevertheless, in a given patient, classical skel...

Descripción completa

Detalles Bibliográficos
Autores principales: Misiorowski, Waldemar, Czajka-Oraniec, Izabela, Kochman, Magdalena, Zgliczyński, Wojciech, Bilezikian, John P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671544/
https://www.ncbi.nlm.nih.gov/pubmed/28900835
http://dx.doi.org/10.1007/s12020-017-1414-2
_version_ 1783276255455477760
author Misiorowski, Waldemar
Czajka-Oraniec, Izabela
Kochman, Magdalena
Zgliczyński, Wojciech
Bilezikian, John P.
author_facet Misiorowski, Waldemar
Czajka-Oraniec, Izabela
Kochman, Magdalena
Zgliczyński, Wojciech
Bilezikian, John P.
author_sort Misiorowski, Waldemar
collection PubMed
description SUMMARY: Although bone disease and stone disease are the universally accepted classical manifestations of primary hyperparathyroidism, clinical parathyroid bone disease is rarely seen today in the United States (<5% of patients) and Western Europe. Nevertheless, in a given patient, classical skeletal involvement can be the first sign of primary hyperparathyroidism, but not recognized because it is not usually included, anymore, in the differential diagnosis of this manifestation of skeletal disease. We describe four cases of primary hyperparathyroidism in which the first clinical manifestation of the disease was a pathological fracture that masqueraded as a malignancy. The presence of large osteolytic lesions gave rise to the initial diagnosis of a primary or metastatic cancer. In none of the reported cases was primary hyperparathyroidism with osteitis fibrosa considered as the diagnosis. It would seem to us that this course is best explained by the fact that in many countries such manifestations of primary hyperparathyroidism have become a rarity. In fact, the incidence of osteitis fibrosa among patients with primary hyperparathyroidism in the US is estimated as so rare, that in majority of medical centers routine x-ray examinations of the bones in these patients is not recommended. The X-ray or computed tomography scan findings of osteitis fibrosa cystica include lytic or multilobular cystic changes. Multiple bony lesions representing brown tumors may be misdiagnosed on computed tomography scan as metastatic carcinoma, bone cysts, osteosarcoma, and especially giant-cell tumor. Distinguishing between primary hyperparathyroidism and malignancy is made readily by the concomitant measurement of parathyroid hormone which in primary hyperparathyroidism, again, will be markedly elevated. In the hypercalcemias of malignancy, such elevations of parathyroid hormone are virtually never seen. CONCLUSION: When radiographic evidence of a lytic lesion and hypercalcemia are present, primary hyperparathyroidism should always be considered in the differential diagnosis.
format Online
Article
Text
id pubmed-5671544
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-56715442017-11-17 Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism Misiorowski, Waldemar Czajka-Oraniec, Izabela Kochman, Magdalena Zgliczyński, Wojciech Bilezikian, John P. Endocrine Clinical Management of Endocrine Diseases SUMMARY: Although bone disease and stone disease are the universally accepted classical manifestations of primary hyperparathyroidism, clinical parathyroid bone disease is rarely seen today in the United States (<5% of patients) and Western Europe. Nevertheless, in a given patient, classical skeletal involvement can be the first sign of primary hyperparathyroidism, but not recognized because it is not usually included, anymore, in the differential diagnosis of this manifestation of skeletal disease. We describe four cases of primary hyperparathyroidism in which the first clinical manifestation of the disease was a pathological fracture that masqueraded as a malignancy. The presence of large osteolytic lesions gave rise to the initial diagnosis of a primary or metastatic cancer. In none of the reported cases was primary hyperparathyroidism with osteitis fibrosa considered as the diagnosis. It would seem to us that this course is best explained by the fact that in many countries such manifestations of primary hyperparathyroidism have become a rarity. In fact, the incidence of osteitis fibrosa among patients with primary hyperparathyroidism in the US is estimated as so rare, that in majority of medical centers routine x-ray examinations of the bones in these patients is not recommended. The X-ray or computed tomography scan findings of osteitis fibrosa cystica include lytic or multilobular cystic changes. Multiple bony lesions representing brown tumors may be misdiagnosed on computed tomography scan as metastatic carcinoma, bone cysts, osteosarcoma, and especially giant-cell tumor. Distinguishing between primary hyperparathyroidism and malignancy is made readily by the concomitant measurement of parathyroid hormone which in primary hyperparathyroidism, again, will be markedly elevated. In the hypercalcemias of malignancy, such elevations of parathyroid hormone are virtually never seen. CONCLUSION: When radiographic evidence of a lytic lesion and hypercalcemia are present, primary hyperparathyroidism should always be considered in the differential diagnosis. Springer US 2017-09-12 2017 /pmc/articles/PMC5671544/ /pubmed/28900835 http://dx.doi.org/10.1007/s12020-017-1414-2 Text en © The Author(s) 2017 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Clinical Management of Endocrine Diseases
Misiorowski, Waldemar
Czajka-Oraniec, Izabela
Kochman, Magdalena
Zgliczyński, Wojciech
Bilezikian, John P.
Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism
title Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism
title_full Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism
title_fullStr Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism
title_full_unstemmed Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism
title_short Osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism
title_sort osteitis fibrosa cystica—a forgotten radiological feature of primary hyperparathyroidism
topic Clinical Management of Endocrine Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671544/
https://www.ncbi.nlm.nih.gov/pubmed/28900835
http://dx.doi.org/10.1007/s12020-017-1414-2
work_keys_str_mv AT misiorowskiwaldemar osteitisfibrosacysticaaforgottenradiologicalfeatureofprimaryhyperparathyroidism
AT czajkaoraniecizabela osteitisfibrosacysticaaforgottenradiologicalfeatureofprimaryhyperparathyroidism
AT kochmanmagdalena osteitisfibrosacysticaaforgottenradiologicalfeatureofprimaryhyperparathyroidism
AT zgliczynskiwojciech osteitisfibrosacysticaaforgottenradiologicalfeatureofprimaryhyperparathyroidism
AT bilezikianjohnp osteitisfibrosacysticaaforgottenradiologicalfeatureofprimaryhyperparathyroidism